Our director, Dr. Bing Ren, has been at the forefront of epigenomic research for over a decade. A pioneer in the field, he has a long and influential record of scientific innovation and leadership as a driving force for multiple genomic consortia, including ENCODE, the NIH Roadmap Epigenomics Mapping Consortium, the International Human Epigenome Consortium, and the 4D Nucleome Consortium. Today, his laboratory is a leader in developing technology to study how the epigenome regulates cellular function.
The Center for Epigenomics mission is to make transformative discoveries through the application of cutting-edge epigenome technology to outstanding biomedical research questions. We seek to advance science and human health by breaking down barriers that prevent the application of epigenomics to basic and clinical research. To this end, we aim to accomplish three goals:
1. Expand the possibilities of epigenomics via technological innovation.
2. Use our unique epigenomic capabilities and expertise to address outstanding questions of science and human health.
3. Serve as the nucleus for world-class collaborative teams, enabling groundbreaking and paradigm-shifting science.